BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26 | -99.5% | 3 | -99.3% | 0.00% | -100.0% |
| Q4 2022 | $4,971 | -0.6% | 433 | -0.7% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | 0.0% | 436 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $5,000 | -61.5% | 430 | -47.0% | 0.00% | -50.0% |
| Q1 2022 | $13,000 | +18.2% | 811 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $11,000 | +22.2% | 811 | +27.9% | 0.00% | +100.0% |
| Q3 2021 | $9,000 | +350.0% | 634 | +331.3% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 147 | -25.8% | 0.00% | -100.0% |
| Q1 2021 | $2,000 | – | 198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |